Ophthalmic Outpatient Department Landspitali UH
Reykjavik, 101, Iceland
NCT Number: NCT06929026
The goal of this observational study is to determine whether oxygen content of the retinal vessels of the eye may serve as a biomarker in Parkinson´s disease. The main questions it aims to answer are:
1. Is retinal vessel oxyhemoglobin saturation and vessel width altered in people with Parkinson´s disease? 2. Is the thickness of the retinal nerve fiber layer altered in people with Parkinson´s disease? 3. Is the response of ganglion cells of the inner retina and the visual cortex altered in people with Parkinson´s disease?
The study procedure is threefold. The participants will:
A. Sit in front of a screen and focus on a red dot of its middle. A simple recording electrodes are applied on the cornea, forehead and scalp for the electrophysiological measurements. Prior to this procedure a topical anesthetic gel is applied to numb the eye to prevent discomfort from placement of the corneal electrodes.
B. Undergo general eye examination and optical coherence tomography (OCT) to measure the retinal tissue thickness. Prior to eye examination,eye drops are applied into the eyes to enlarge the pupils C. Sit in front of a fundus camera for obtaining images of the retinal vessels to measure oxygen saturation and the vessel width
Researchers will compare the obtained measurements with age- and gender matching of healthy controls.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Reykjavik, 101, Iceland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline. On the visit to the ambulatory Opthalamic department at Landspitali
Obtained by retinal oximetry
Time frame: Baseline. On the visit to the ambulatory Opthalamic department at Landspitali
Obtained by retinal oximetry
Time frame: Baseline. On the visit to the ambulatory Opthalamic department at Landspitali
Obtained by cross-sectional imaging of the retinal tissue (OCT)
Time frame: Baseline. On the visit to the ambulatory Opthalamic department at Landspitali
Pattern electroretinogram (PERG)
Time frame: Baseline. On the visit to the ambulatory Opthalamic department at Landspitali
Amplitude of the visual evoked potential response
Landspitali University Hospital
Other
Retinal Biomarkers in Parkinson´s Disease: Retinal Oximetry, Pattern Electroretinography (PERG), Visual Evoked Potentials (VEP) and Optical Coherence Tomography (OCT)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06260228
Basal Ganglia Diseases, Brain Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT04691661
Basal Ganglia Diseases, Brain Diseases
Lille, France
View Trial DetailsNCT04426786
Basal Ganglia Diseases, Behavior
Vancouver, British Columbia, Canada
View Trial DetailsNCT06846658
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Sesto Fiorentino, FI, Italy
View Trial Details